Logo Logo
Switch Language to German

Rankenberg, Johanna; Rakete, Stefan; Wagner, Brandie D.; Patnaik, Jennifer L.; Henning, Christian; Lynch, Anne; Glomb, Marcus A. and Nagaraj, Ram H. (2021): Advanced glycation end products in human diabetic lens capsules. In: Experimental Eye Research, Vol. 210, 108704

Full text not available from 'Open Access LMU'.


Advanced glycation end products (AGEs) accumulate with age in human lens capsules. AGEs in lens capsules potentiate the transforming growth factor beta-2-mediated mesenchymal transition of lens epithelial cells, which suggests that they play a role in posterior capsule opacification after cataract surgery. We measured AGEs by liquid chromatography-mass spectrometry in capsulorhexis specimens obtained during cataract surgery from nondiabetic and diabetic patients with and without established retinopathy. Our data showed that the levels of most AGEs (12 out of 13 measured) were unaltered in diabetic patients and diabetic patients with retinopathy compared to nondiabetic patients. There was one exception: glucosepane, which was significantly higher in diabetic patients, both with (6.85 pmol/mu mol OH-proline) and without retinopathy (8.32 pmol/mu mol OHproline), than in nondiabetic patients (4.01 pmol/mu mol OH-proline). Our study provides an explanation for the similar incidence of posterior capsule opacification between nondiabetic and diabetic cataract patients observed in several studies.

Actions (login required)

View Item View Item